You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sALCL

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic Trial in China (Brentuximab Vedotin)

Completed
Has Results
  • Hodgkin Disease
  • Lymphoma, Large-Cell, Anaplastic
  • Brentuximab Vedotin
  • Beijing, Beijing, China
  • +6 more
Feb 3, 2021

Patterns and Disease Control in cHL and sALCL in Routine

Completed
  • Hodgkin Disease
  • Lymphoma, Large-cell, Anaplastic
    • Astrakhan, Russian Federation
    • +49 more
    Dec 19, 2022

    Relapsed or Refractory CD30+ Malignancies When Re-treated With

    Completed
    • Hodgkin Disease
    • Lymphoma, T-Cell, Cutaneous
    • No Intervention
    • San Bartolome, Alicante, Spain
    • +29 more
    Jul 28, 2022

    Hodgkin Lymphoma, Peripheral T Cell Lymphoma, Anaplastic Large Cell Lymphoma Trial in United States (brentuximab vedotin)

    Terminated
    • Hodgkin Lymphoma
    • +2 more
    • brentuximab vedotin
    • Anaheim, California
    • +18 more
    Dec 6, 2022

    Peripheral T Cell Lymphoma Trial in France (Chemotherapy + follow up, Chemotherapy + ASCT + follow up)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Chemotherapy + follow up
    • Chemotherapy + ASCT + follow up
    • Amiens, France
    • +47 more
    Aug 2, 2022

    Anaplastic Large-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma Trial in Worldwide (brentuximab vedotin, doxorubicin,

    Completed
    Has Results
    • Anaplastic Large-Cell Lymphoma
    • +2 more
    • brentuximab vedotin
    • +4 more
    • Gilbert, Arizona
    • +143 more
    Nov 1, 2021

    A Study of People With CD30 Positive Lymphoma in China

    Not yet recruiting
    • Lymphoma
      • (no location specified)
      Aug 17, 2022

      Relapsed or Refractory Hodgkin Lymphoma, Relapsed or Refractory Anaplastic Large-cell Lymphoma Trial in Worldwide (Brentuximab

      Completed
      Has Results
      • Relapsed or Refractory Hodgkin Lymphoma
      • Relapsed or Refractory Anaplastic Large-cell Lymphoma
      • Brentuximab vedotin
      • Aurora, Colorado
      • +17 more
      Nov 12, 2018

      Non-Hodgkin Lymphoma (NHL), Cutaneous Lymphoma, Cutaneous T-cell Lymphoma (CTCL) Trial in Stanford (Brentuximab vedotin)

      Completed
      Has Results
      • Non-Hodgkin Lymphoma (NHL)
      • +4 more
      • Brentuximab vedotin
      • Stanford, California
        Stanford University School of Medicine
      Feb 17, 2017

      Hodgkin Lymphoma, Anaplastic Large-cell Lymphoma Trial in Belgium, Lithuania, Spain (brentuximab vedotin, Brentuximab vedotin

      Completed
      Has Results
      • Hodgkin Lymphoma
      • Anaplastic Large-cell Lymphoma
      • brentuximab vedotin
      • Brentuximab vedotin and rifampicin
      • Brussels, Belgium
      • +5 more
      Mar 30, 2016